Continuous glucose monitoring improves glycemic outcomes in children with type 1 diabetes: real-world data from a population-based clinic
Sanderson EE, Abraham MB, Smith GJ, et al.
Diabetes Care. Pub. online 19 July 2021.
Leggi
Breaking news
Development of a life expectancy table for individuals with type 1 diabetes
Tran-Duy A, Knight J, Clarke PM, et al.
Diabetologia. Pub. online 26 July 2021
Leggi
SGLT2 inhibitors and GLP-1 receptor agonists: established and emerging indications
Brown E, Heerspink HJL, Cuthbertson DJ, et al.
Lancet. 2021;398(10296):262-276
Leggi
Echocardiographic predictors of long‐term adverse cardiovascular outcomes in participants with and without diabetes mellitus: A follow‐up analysis of the Copenhagen City Heart Study
Özbek BT, Modin D, Møgelvang R, et al.
Diabet Med. Pub. online 12 July 2021
Leggi
A guideline for the outpatient management of glycaemic control in people with cancer
Joharatnam-Hogan N, Chambers P, Dhatariya K, et al.
Diabet Med. 2021;e14636.
Leggi
Usefulness of glucagon-like peptide-1 receptor agonists to reduce adverse cardiovascular disease events in patients with type 2 diabetes mellitus
Grewal S, Zaman N, Borgatta L, et al.
Am J Cardiol. 2021;S0002-9149(21)00522-1.
Leggi
Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes
Frías JP, Davies MJ, Rosenstock J, et al.
N Engl J Med. Pub. online 25 June 2021.
Leggi
Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes
Gerstein HC, Sattar N, Rosenstock J, et al.
NEJM. Pub. online 28 June 2021.
Leggi
Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes.
Søholm, JC, Vestgaard M, Ásbjörnsdóttir B, et al.
Diabetologia. Pub. online 19 Jun 2021.
Leggi
Cholesterol control for subclinical coronary atherosclerosis in subjects without indication for statin therapy
Park HW, Kim YG, Park GM, et al.
Am J Cardiol. 2021;S0002-9149(21)00493-8.
Leggi